Home > Insider Trading > Celldex Therapeutics Inc.

Celldex Therapeutics Inc. (CLDX)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

First
<< Previous
11 - 20
Next >>

Hedge Funds Have Never Been This Bullish On Celldex Therapeutics, Inc. (CLDX)

The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 823 13F filings that hedge funds and well-known value investors are required to file by the SEC.

Keep Reading →

October 6th, 2020 - Hedge Funds News

Hedge Funds Are Dumping Celldex Therapeutics, Inc. (CLDX)

We at Insider Monkey have gone over 821 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio positions as of March...

Keep Reading →

May 28th, 2020 - Hedge Funds News

Is Celldex Therapeutics, Inc. (CLDX) A Good Stock To Buy?

We are still in an overall bull market and many stocks that smart money investors were piling into surged through the end of November.

Keep Reading →

December 23rd, 2019 - Hedge Funds News

Hedge Fund and Insider Trading News: King Street Capital, Third Point LLC, Alta Mesa Resources Inc (AMR), HubSpot Inc (HUBS), MYnd Analytics Inc (MYND), and More

TOKYO—New York-based hedge fund King Street Capital Management LP has proposed new independent directors at Toshiba Corp., according to people familiar with the matter, the first indication of dissatisfaction...

Keep Reading →

August 31st, 2018 - Hedge Funds Insider Trading

Is Celldex Therapeutics, Inc. (CLDX) a Good Stock To Buy?

Legendary investors such as Leon Cooperman and Seth Klarman earn enormous amounts of money for themselves and their investors by doing in-depth research on small-cap stocks that big brokerage houses don...

Keep Reading →

December 10th, 2016 - Hedge Funds News

Three Cancer Plays For The Fourth Quarter Of 2016

We are now into the final quarter of 2016, and there looks set to be plenty of activity across the biotech space before the year draws to a close.

Keep Reading →

October 5th, 2016 - News

Here's Why These Five Stocks Are Gaining Ground Today

In spite of better-than-expected April retail sales data, U.S.

Keep Reading →

May 13th, 2016 - Market Movers News

Hedge Funds Wisely Fled These Tanking Stocks

The importance of hedge fund sentiment is not only reflected by the long positions that these firms take in high flying companies, but also how quickly are they able to back out from investments turning...

Keep Reading →

May 8th, 2016 - Hedge Funds News

Here is What Hedge Funds Think About Celldex Therapeutics, Inc. (CLDX)

Looking for high-potential stocks? Just follow the big players within the hedge fund industry. Why should you do so? Let’s take a brief look at what statistics have to say about hedge funds’ stock...

Keep Reading →

December 14th, 2015 - Hedge Funds News

Dendreon Corporation (DNDN), Celldex Therapeutics, Inc. (CLDX): Is There Still Upside in Immunotherapy?

Three years ago, cancer immunotherapy was the hottest thing in biotech, as Dendreon Corporation (NASDAQ:DNDN)'s Provenge earned approval from the Food and Drug Administration and had blockbuster potential...

Keep Reading →

September 12th, 2013 - News